If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
In this video, MSF staff working in places where people have been severely affected by COVID-19 speak out about their experiences, and how the lack of access to COVID-19 vaccines has impacted the communities where they work.